Recently, it has been shown that the frequency of CD38+ HLA-DR+ CD8 T cells was elevated in COVID-19 patients who had a concomitant infection with other pathogens but were not impacted by pre-existing immunosuppression or treatment with steroids [15]. This evidence concerns the gene CD8A and COVID-19.